Rights and permissions
About this article
Cite this article
Mono- and dual therapy with rifaximin* yields `low eradication rates' of Helicobacter pylori,. Inpharma Wkly. 1093, 8 (1997). https://doi.org/10.1007/BF03315194
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03315194